AI Calcium Scoring Gets CMS Payment

Bunkerhill Health secured FDA clearance and CMS reimbursement for AI cardiac screening — what it means for the incidental findings market

We just got paid to find heart disease hiding in plain sight.

Bunkerhill Health secured both FDA clearance and CMS reimbursement for AI-powered coronary artery calcium detection on routine chest CTs — becoming the first company to unlock a reimbursement pathway that the cardiovascular and radiology communities have been working toward for years.

📊 The significance of this milestone extends beyond Bunkerhill specifically. The FDA clearance establishes that AI-powered incidental CAC detection meets the evidentiary standard for clinical deployment. The CMS reimbursement code establishes that the finding has sufficient clinical value to justify payment. Together, they create the commercial foundation for a new category of AI diagnostic tool — incidental cardiac screening — that can scale across the tens of millions of chest CTs performed annually in the US.

The clinical case is well established. Coronary artery calcium is a direct measure of atherosclerotic plaque burden in the coronary art…